Crossmark

Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones

Crossref DOI link: https://doi.org/10.1039/C7OB03138F

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Bahou, Calise

Richards, Daniel A. https://orcid.org/0000-0001-8827-9170
Maruani, Antoine https://orcid.org/0000-0002-8677-8977
Love, Elizabeth A. https://orcid.org/0000-0003-4403-8791
Javaid, Faiza

Caddick, Stephen

Baker, James R. https://orcid.org/0000-0002-7223-2279
Chudasama, Vijay https://orcid.org/0000-0002-8876-3285
Funding

Funding for this research was provided by:

Engineering and Physical Sciences Research Council (173621, EP/M01792X/1, EP/K031953/1)

University College London

Wellcome Trust
License Information

Version of Record valid from 2018-04-11
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Daniel A. Richards (ORCID)

: Daniel A. Richards (ResearcherID)

: Antoine Maruani (ORCID)

: Antoine Maruani (ResearcherID)

: Elizabeth A. Love (ORCID)

: James R. Baker (ORCID)

: Vijay Chudasama (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 19 December 2017; Accepted 29 January 2018; Accepted Manuscript published 29 January 2018; Advance Article published 6 February 2018; Version of Record published 21 February 2018